![]() | Up a level |
Journal Article
Garcia-Marquez, M. A., Thelen, M., Bauer, E., Wennhold, K., Lehmann, J., Keller, D., Gathof, B., Maas, L., George, J., Bruns, C., Quaas, A., von Bergwelt-Baildon, M., Peifer, M. and Schloesser, H. A. (2021). GENOMIC HLA HOMOZYGOSITY IS FREQUENT IN ESOPHAGEAL ADENOCARCINOMA AND RELATED TO LOW IMMUNOGENICITY. J. Immunother. Cancer, 9. S. A1 - 2. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426
Lehmann, J., Thelen, M., Schran, S., Preugszat, E., Wennhold, K., Garcia-Marquez, M., Lohneis, P., Loeser, H., Popp, F., Kruger, S., Boeck, S., Ormanns, S., Rudelius, M., von Bergwelt, M., Bruns, C., Quaas, A. and Schloesser, H. (2022). ORGANIZATION, FUNCTION AND GENE EXPRESSION OF TERTIARY LYMPHOID STRUCTURES IN PANCREATIC CANCER RESEMBLES LYMPHOID FOLLICLES IN SECONDARY LYMPHOID ORGANS AND THEIR ABUNDANCE IS RELATED TO SUPERIOR SURVIVAL. J. Immunother. Cancer, 10. S. A13 - 1. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426
Marquez, Ma Garcia, Thelen, M., Bauer, E., Wennhold, K., Lehmann, J., Keller, D., Maas, L., Nicolik, M., George, J., Zander, T., Schroeder, W., Mueller, P., Bruns, C., Thomas, R., Gathof, B., Quaas, A., Hillmer, A. M., Peifer, M., von Bergwelt-Baildon, M. and Schloesser, H. A. (2022). HEREDITARY HOMOZYGOSITY AND ALLELIC IMBALANCE OF HLA AS COMMON IMMUNE ESCAPE MECHANISMS IN ESOPHAGEAL ADENOCARCINOMA. J. Immunother. Cancer, 10. S. A38 - 1. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426
Schloesser, H. A., Thelen, M., Lechner, A., Gilles, R., Garcia-Marquez, M., Wennhold, K., Alakus, H., Schroeder, W., Moenig, S., Theurich, S., Shimabukuro-Vornhagen, A., Gathof, B., Drebber, U., Quaas, A., Bruns, C., Hoelscher, A. H. and von Bergwelt-Baildon, M. (2017). Tumor-associated B cells and humoral immune response in esophago-gastric adenocarcinoma. Oncol. Res. Treat., 40. S. 159 - 160. BASEL: KARGER. ISSN 2296-5262
Schlosser, H. A., Thelen, M., Dieplinger, G., von Bergwelt-Baildon, A., Garcia-Marquez, M., Reuter, S., Shimabukuro-Vornhagen, A., Wennhold, K., Haustein, N., Buchner, D., Heiermann, N., Kleinert, R., Wahba, R., Ditt, V., Kurschat, C., Cingoz, T., Becker, J., Stippel, D. L. and von Bergwelt-Baildon, M. (2017). Prospective Analyses of Circulating B Cell Subsets in ABO-Compatible and ABO-Incompatible Kidney Transplant Recipients. Am. J. Transplant., 17 (2). S. 542 - 551. HOBOKEN: WILEY. ISSN 1600-6143
Schran, S., Datta, R., Persa, O., Aguilar, C., Thelen, M., Lehmann, J., Garcia-Marquez, M., Wennhold, K., Quaas, A., Bruns, C., Mauch, C., Loeser, H., Stippel, D. and Schloesser, H. (2021). T- AND B-CELL ABUNDANCE ARE REMARKABLY REDUCED IN THE IMMUNE MICROENVIRONMENT OF POST-TRANSPLANT MALIGNANCIES. J. Immunother. Cancer, 9. S. A7 - 2. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426
Thelen, M., Keller, D., Lehmann, J., Wennhold, K., Weitz, H., Bauer, E., Gathof, B., Brueggemann, M., Kotrova, M., Quaas, A., Mallmann, C., Chon, S., Hillmer, A. M., Bruns, C., von Bergwelt-Baildon, M., Garcia-Marquez, M. A. and Schloesser, H. A. (2022). IMMUNE RESPONSES AGAINST SHARED ANTIGENS ARE COMMON IN ESOPHAGO-GASTRIC CANCER AND CAN BE ENHANCED USING CD40-ACTIVATED B CELLS. J. Immunother. Cancer, 10. S. A24 - 1. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426
Thelen, M., Lechner, A., Schloesser, H., Rothschild, S., Wennhold, K., Beutner, D. and von Bergwelt-Baildon, M. (2017). Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma (HNSCC). Oncol. Res. Treat., 40. S. 251 - 252. BASEL: KARGER. ISSN 2296-5262
Theurich, S., Becker, H. J., Malcher, J., Marquez, M. G., Wennhold, K., Reuter, S., Shimabukuro-Vornhagen, A., Schloesser, H. A., Huelsemann, M., Frenzel, L. P. and von Bergwelt-Baildon, M. (2017). Hypoxia and iron-chelation decrease antigen-presenting functions in CD40-activated human B cells. Oncol. Res. Treat., 40. S. 255 - 256. BASEL: KARGER. ISSN 2296-5262
Theurich, S., Iltgen, J., Wennhold, K., Marquez, M. Garcia, Rothschild, S., Schneider, B., Holtick, U., Thelen, M., Scheid, C., Becker, Hj, Schloesser, H., Reuter, S., Vornhagen, A. Shimabukuro and von Bergwelt-Baildon, M. (2016). THE JAK1/2 INHIBITOR RUXOLITINIB MODULATES ANTIGEN PRESENTING FUNCTIONS OF ACTIVATED PRIMARY B CELLS ON A METABOLIC LEVEL. Haematologica, 101. S. 462 - 463. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Theurich, S., Iltgen-Brebuda, J., Thelen, M., Wennhold, K., Rothschild, S., Becker, H., Schloesser, H., Shimabukuro-Vornhagen, A. and von Bergwelt-Baildon, M. (2017). Ruxolitinib modulates the antigen presenting function of activated B cells by interfering with metabolic pathways. Oncol. Res. Treat., 40. S. 262 - 263. BASEL: KARGER. ISSN 2296-5262
Theurich, S., Schlaak, M., Steguweit, H., Heukamp, L. C., Wennhold, K., Kurschat, P., Rabenhorst, A., Hartmann, K., Shimabukuro-Vornhagen, A., Schloesser, H., Holtick, U., Hallek, M., Stadler, R. and von Bergwelt-Baildon, M. (2014). Tumor infiltrating B-cells in primary cutaneous T-cell lymphoma correlate with disease progression and might represent a novel target for immunotherapy. Exp. Dermatol., 23 (3). S. E25 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Theurich, S., Schlaak, M., Steguweit, H., Heukamp, L. C., Wennhold, K., Kurschat, P., Shimabukuro-Vornhagen, A., Schloesser, H., Holtick, U., Hallek, M., Stadler, R. and von Bergwelt-Baildon, M. (2014). Tumor infiltrating B-cells in primary cutaneous T-cell lymphoma correlate with disease progression and might represent a novel target for immunotherapy. Oncol. Res. Treat., 37. S. 31 - 32. BASEL: KARGER. ISSN 2296-5262
Wennhold, K., Thelen, M., Garcia-Marquez, M., Shimabukuro-Vornhagen, A. and von Bergwelt-Baildon, M. (2016). Tumorantigen-specific CD40B cells - combining enhanced antigen-presentation and antibody-secretion for tumor targeting. Oncol. Res. Treat., 39. S. 7 - 8. BASEL: KARGER. ISSN 2296-5262
Wennhold, K., Thelen, M., Lechner, A., Schloesser, H. and von Bergwelt-Baildon, M. (2018). CD86+antigen-presenting B cells are increased in solid cancers and induce tumor antigen-specific T cell responses. Oncol. Res. Treat., 41. S. 235 - 236. BASEL: KARGER. ISSN 2296-5262
Wennhold, K., Thelen, M., Schloesser, H., Shimabukuro-Vornhagen, A. and von Bergwelt-Baildon, M. (2017). Using antigen-specific B cells to combine antibody and T cell based cancer immunotherapy. Oncol. Res. Treat., 40. S. 241 - 242. BASEL: KARGER. ISSN 2296-5262
Wennhold, K., Thelen, M., Shimabukuro-Vornhagen, A. and von Bergwelt-Baildon, M. (2015). In vitro and in vivo imaging of the migratory behavior of tumorantigen-specific CD40-activated B cells in the setting of B cell-based cancer immunotherapy. Oncol. Res. Treat., 38. S. 170 - 171. BASEL: KARGER. ISSN 2296-5262
Zimmer, S., Schloesser, H., Wennhold, K., Thelen, M., Garcia-Marquez, M. and von Bergwelt-Baildon, M. (2016). Characterization of B-cell subsets in renal cell carcinoma. Oncol. Res. Treat., 39. S. 19 - 20. BASEL: KARGER. ISSN 2296-5262